UNSPSC 51152037: Mephenoxalone

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51152037

Definition

This classification denotes a muscle relaxant with the molecular formula C11H13NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CZ87T54W8W, chemically known as 2-oxazolidinone, 5-((o-methoxyphenoxy)methyl)- but generally known as mephenoxalone, which bears US NIH Compound Identifier 6257. European Medicines Agency schedules Mephenoxalone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08747MIG.

Read the full definition

The term MEPHENOXALONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules mephenoxalone in its Anatomical Therapeutic Chemical (ATC) Classification. MEPHENOXALONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mephenoxalone under HS 29349990 and SITC 51579. As of Q4 2014, MEPHENOXALONE remains the US FDA Preferred Term for this commodity.

Mephenoxalone bears US NLM identifiers UMLS ID C0065959 and NCI Concept Code C83930. SMILES: COC1=CC=CC=C1OCC2CNC(=O)O2.

About UNSPSC 51152037

UNSPSC 51152037 Mephenoxalone is a Commodity code designated for pharmaceutical products, though recent state and local solicitations tagged under this code show misalignment with the nominal scope. The two recent opportunities on file involve naloxone procurement and pharmacy benefit management services—both distinct from mephenoxalone itself. State and local governments are using this code tag to solicit pharmaceutical-adjacent services and harm-reduction products through competitive bidding processes, though the actual commodities being purchased do not match the specific chemical name assigned to the code. Issuing bodies include county health departments and state health and human services agencies conducting both traditional IFB procurements and exploratory RFI market-research activities.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with responses due July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a direct-to-manufacturer prescription program outside traditional pharmacy benefit manager and group purchasing organization channels. The code shows sparse recent activity and exhibits a mismatch between its nominal scope (mephenoxalone, a specific pharmaceutical) and the actual procurement work being tagged under it. Prospective vendors should note that the code's application in current state and local procurement does not reflect its official UNSPSC definition, and activity remains limited to two jurisdictions with distinct procurement objectives.

Quick answers

What is UNSPSC 51152037?

UNSPSC 51152037 is Mephenoxalone, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51152037?

UNSPSC 51152037 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51152037

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code